Changes in the gastric mucosa of the mouse associated with long lasting unsurmountable histamine H2 blockade.
- 1 November 1986
- Vol. 27 (11) , 1338-1346
- https://doi.org/10.1136/gut.27.11.1338
Abstract
The oral administration of loxtidine to mice at doses of 600, 250, and 50 mg/kg/day for 746 days produced carcinoid tumours of the gastric fundus. The fundic mucosa also showed marked atypical hyperplasia with changes in foveolar cells similar to those seen in early incomplete metaplasia. These effects may be related to the prolonged achlorhydria produced by this potent unsurmountable histamine H2 receptor antagonist.This publication has 15 references indexed in Scilit:
- Plasma gastrin and gastric enterochromaffinlike cell activation and proliferationGastroenterology, 1986
- Inhibition of acid and gastric carcinoids.Gut, 1985
- Pharmacological basis for the induction of gastric carcinoid tumours in the rat by loxtidine, an unsurmountable histamine H2‐receptor blocking drugBritish Journal of Pharmacology, 1985
- NON-A, NON-B HEPATITIS AND INTRAVENOUS IMMUNOGLOBULINThe Lancet, 1985
- Neuron Specific Enolase: A Common Marker for the Endocrine Cells and Innervation of the Gut and PancreasGastroenterology, 1982
- Endocrine cells of the gastrointestinal tract and related tumors.1979
- Comparative histochemistry of gastrointestinal mucosubstancesJournal of Anatomy, 1976
- Naturally Occurring Tumors and Other Lesions of the Digestive Tract in Untreated C57BL MiceJNCI Journal of the National Cancer Institute, 1969
- Fine structure of intestinal metaplasia and adenocarcinoma of the human stomach.1968
- Hyperplastic and Neoplastic Lesions of the Glandular Stomach and Intestine in Two Inbred Strains of Mice and their Reciprocal HybridsBritish Journal of Cancer, 1956